The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia. The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or in clinical trial studies who would have these tools available. We present criteria for all-cause dementia and for AD dementia. We retained the general framework of probable AD dementia from the 1984 criteria. On the basis of the past 27 years of experience, we made…

• AA
  Alzheimer's Association
• BS
  Bristol-Myers Squibb
• EL
  Eli Lilly and Company
• P
  Pfizer
• BI
  Baxter International
• D
  Danone
• UC
  University College London
• E
  Eisai
• S
  Servier
• HL
  H. Lundbeck A/S
• LC
  Lundbeck Canada
• NI
  National Institutes of Health
• JA
  Johnson and Johnson
• FB
  Fidelity Biosciences
• GH
  GE Healthcare
• PC
  Pfizer Canada
• AR
  Avid Radiopharmaceuticals
• PP
  Pfizer Pharmaceuticals
• NI
  National Institute on Aging
• FP
  Forest Pharmaceuticals